The Kidney Research Network (KRN) was founded  in 2015 to strategically focus patients, clinicians, scientists and public and private partners to bring safe and effective therapies to patients affected by proteinuric kidney diseases.

 

The program is supported by a Patient Advisory Board and consists of the following cores: Clinical Trials Network, Clinical Trials Consulting Team, Data Analysis and Coordinating Center, Data Warehouse, and Endpoints and Outcomes Consortium.

​

The KRN uses quality initiatives, health education, clinical trials, and patient-clinician-scientist-industry partnerships to achieve its goals.